Tülay Çevlik
Research Subjects
Tülay Çevlik has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Goncagul Haklar
Department of Biochemistry, School of Medicine, Marmara University, Istanbul, Turkey
6 shared publications - Rana Turkal
Marmara University Pendik Education and Research Hospital
4 shared publications - Onder Sirikci
Marmara University School of Medicine, Department of Biochemistry, Istanbul, Turkey
3 shared publications - Ahmet Faruk Tekin
School of Medicine, Marmara University
1 shared publication - Ali Yaman
Department of Biochemistry, School of Medicine, Marmara University, Istanbul, Turkey
1 shared publication Arzu İlki
Dept. of Microbiology, School of Medicine, Marmara University, Istanbul, Turkey
1 shared publication
Latest Publications
- 18 February 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
Thrombin Generation Measurement: A Novel Diagnostic and Prognostic Approach for Identifying Early-Stage Disseminated Intravascular Coagulation in Individuals with Sepsis
Background: Disseminated intravascular coagulation (DIC) is a complex hemostatic disorder characterized by simultaneous thrombosis and bleeding and is frequently observed in sepsis. Traditional coagulation assays such as prothrombin time (PT) and activated partial thromboplastin time (aPTT) primarily assess the initiation of clot formation but fail to capture the dynamic balance between procoagulant and anticoagulant forces. The thrombin generation (TG) assay provides a more comprehensive evaluation of coagulation, incorporating both propagation and decay phases, and may offer additional insight into sepsis-associated coagulopathy. This study investigated the diagnostic and prognostic utility of TG parameters across graded stages of DIC in septic intensive care unit (ICU) patients. Methods: In this prospective observational study, 53 adult septic ICU patients contributed 151 plasma samples obtained longitudinally. Patients were classified as non-DIC, non-overt DIC, or overt DIC according to International Society on Thrombosis and Haemostasis criteria. Standard coagulation parameters and TG profiles were measured. Associations with DIC severity were examined using cumulative link mixed models with patient-level random effects. Sensitivity analyses explored transition-specific TG behavior. ICU mortality was evaluated using multivariable logistic regression and ROC analysis. Results: In univariate analyses, both conventional coagulation markers and TG parameters were associated with increasing DIC severity. In the final multivariable model, prolonged PT and aPTT, elevated D-dimer, and lower platelet count were the strongest independent predictors of DIC severity, whereas StartTail provided complementary kinetic information. Longitudinal analyses demonstrated progressive prolongation of StartTail and attenuation of reverse velocity index with advancing DIC stage and increasing SOFA scores, indicating worsening dysregulation of thrombin inactivation. Conclusion: TG parameters, particularly late-phase kinetic features, reflect dynamic and stage-specific dysregulation of coagulation in sepsis-associated DIC. Although TG measures do not outperform conventional coagulation tests, they provide complementary mechanistic insight into thrombin regulation and consumptive coagulopathy. Larger multicenter studies are warranted to validate these findings.
- 18 February 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
Thrombin Generation Measurement: A Novel Diagnostic and Prognostic Approach for Identifying Early-Stage Disseminated Intravascular Coagulation in Individuals with Sepsis
Background: Disseminated intravascular coagulation (DIC) is a complex hemostatic disorder characterized by simultaneous thrombosis and bleeding and is frequently observed in sepsis. Traditional coagulation assays such as prothrombin time (PT) and activated partial thromboplastin time (aPTT) primarily assess the initiation of clot formation but fail to capture the dynamic balance between procoagulant and anticoagulant forces. The thrombin generation (TG) assay provides a more comprehensive evaluation of coagulation, incorporating both propagation and decay phases, and may offer additional insight into sepsis-associated coagulopathy. This study investigated the diagnostic and prognostic utility of TG parameters across graded stages of DIC in septic intensive care unit (ICU) patients. Methods: In this prospective observational study, 53 adult septic ICU patients contributed 151 plasma samples obtained longitudinally. Patients were classified as non-DIC, non-overt DIC, or overt DIC according to International Society on Thrombosis and Haemostasis criteria. Standard coagulation parameters and TG profiles were measured. Associations with DIC severity were examined using cumulative link mixed models with patient-level random effects. Sensitivity analyses explored transition-specific TG behavior. ICU mortality was evaluated using multivariable logistic regression and ROC analysis. Results: In univariate analyses, both conventional coagulation markers and TG parameters were associated with increasing DIC severity. In the final multivariable model, prolonged PT and aPTT, elevated D-dimer, and lower platelet count were the strongest independent predictors of DIC severity, whereas StartTail provided complementary kinetic information. Longitudinal analyses demonstrated progressive prolongation of StartTail and attenuation of reverse velocity index with advancing DIC stage and increasing SOFA scores, indicating worsening dysregulation of thrombin inactivation. Conclusion: TG parameters, particularly late-phase kinetic features, reflect dynamic and stage-specific dysregulation of coagulation in sepsis-associated DIC. Although TG measures do not outperform conventional coagulation tests, they provide complementary mechanistic insight into thrombin regulation and consumptive coagulopathy. Larger multicenter studies are warranted to validate these findings.
- Open Access
- 1 January 2026
- Published by Kare Publishing in International Journal of Medical Biochemistry
- Vol. 9 (4) , 232-241
Interpretation of heterophile-blocking tube results in thyroid function testing using analytical change limits: An exploratory study of clinically discordant cases
- 1 January 2026
- Published by Kare Publishing in International Journal of Medical Biochemistry
- Vol. 9 (4) , 232-241
Open AccessInterpretation of heterophile-blocking tube results in thyroid function testing using analytical change limits: An exploratory study of clinically discordant cases
- Open Access
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 43 (1) , 43-49
Six SIGMA evaluation of 17 biochemistry parameters using bias calculated from internal quality control and external quality assurance data
Background: Six Sigma is a popular quality management system that enables continuous monitoring and improvement of analytical performance in the clinical laboratory. We aimed to calculate sigma metrics and quality goal index (QGI) for 17 biochemical analytes and compare the use of bias from internal quality control (IQC) and external quality assurance (EQA) data in the calculation of sigma metrics. Methods: This retrospective study was conducted in Marmara University Pendik E&R Hospital Biochemistry Laboratory. Sigma metrics calculation was performed as (TEa-bias)/CV). CV was calculated from IQC data from June 2018 - February 2019. EQA bias was calculated as the mean of % deviation from the peer group means in the last seven surveys, and IQC bias was calculated as (laboratory control result mean-manufacturer control mean)/ manufacturer control mean) x100. In parameters where sigma metrics were <5; QGI=bias/1.5 CV) score of 1.2 pointed inaccuracy, and 0.8-1.2 showed both imprecision and inaccuracy. Results: Creatine kinase (both levels), iron and magnesium (pathologic levels) showed an ideal performance with ≥6 sigma level for both bias determinations. Eight of the 17 parameters had different sigma levels when we compared sigma values calculated from EQA and IQC derived bias% while the rest were grouped at the same levels. Conclusions: Sigma metrics is a good quality tool to assess a laboratory's analytical performance and facilitate the comparison of the assay performances in the same manner across multiple systems. However, we might need to design a tight internal quality control protocol for analytes showing poor assay performance.
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 43 (1) , 43-49
Open AccessSix SIGMA evaluation of 17 biochemistry parameters using bias calculated from internal quality control and external quality assurance data
Background: Six Sigma is a popular quality management system that enables continuous monitoring and improvement of analytical performance in the clinical laboratory. We aimed to calculate sigma metrics and quality goal index (QGI) for 17 biochemical analytes and compare the use of bias from internal quality control (IQC) and external quality assurance (EQA) data in the calculation of sigma metrics. Methods: This retrospective study was conducted in Marmara University Pendik E&R Hospital Biochemistry Laboratory. Sigma metrics calculation was performed as (TEa-bias)/CV). CV was calculated from IQC data from June 2018 - February 2019. EQA bias was calculated as the mean of % deviation from the peer group means in the last seven surveys, and IQC bias was calculated as (laboratory control result mean-manufacturer control mean)/ manufacturer control mean) x100. In parameters where sigma metrics were <5; QGI=bias/1.5 CV) score of 1.2 pointed inaccuracy, and 0.8-1.2 showed both imprecision and inaccuracy. Results: Creatine kinase (both levels), iron and magnesium (pathologic levels) showed an ideal performance with ≥6 sigma level for both bias determinations. Eight of the 17 parameters had different sigma levels when we compared sigma values calculated from EQA and IQC derived bias% while the rest were grouped at the same levels. Conclusions: Sigma metrics is a good quality tool to assess a laboratory's analytical performance and facilitate the comparison of the assay performances in the same manner across multiple systems. However, we might need to design a tight internal quality control protocol for analytes showing poor assay performance.
- 3 May 2023
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 21 (1) , 013-022
Tam Kan Sayımında Performans Değerlendirmesi: Sigma Değerleri ve Kalite Hedefi İndeksleri
Amaç: Altı Sigma, klinik laboratuvardaki testlerin performansının izlenmesinde ve iyileştirilmesinde yardımcı olan bir kalite yönetim aracıdır. Kalite hedefi indeksi (quality goal index, QGI) oranı, doğruluk ve kesinlik ile ilgili kalite hedeflerini karşılama durumunu gösterir. Bu çalışmada, Avrupa Dış Kalite Değerlendirme Birliği (European Society for External Quality Assessment, ESFEQA) toplam izin verilen hata (TEa) değerlerini kullanarak tam kan sayımı testleri için sigma değerlerini ve kalite hedefi indeks oranlarını hesaplamayı amaçladık. Gereç ve Yöntem: Çalışmamız Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi Biyokimya Laboratuvarı Hematoloji Ünitesinde retrospektif olarak yapıldı. Testlerin %bias, %CV, TEa değerleri ile Sigma = (TEa - bias)/CV ve QGI= Bias/1.5 CV formülleri kullanılarak hesaplamalar yapıldı. Bulgular: Testlerin sigma düzeyleri ve QGI oranları değerlendirildi. Kullanılan internal kalite kontrol materyallerine göre WBC (tüm seviyeler), RBC (seviye 3), hemoglobin (seviye 2), hematokrit (seviye 2 ve 3), MCV (seviye 2 ve 3) parametrelerinin belirtilen örnekler için performansları >6 sigma ile ideal olarak değerlendirildi. RBC ve hemoglobin parametrelerinin 1.düzey kalite kontrol örneği için performansı ≥3-<4 sigma ile iyi değil olarak kabul edildi. Sigma düzeyi<5 olan parametreler içinde QGI değerleri 1.2 olanlar (PLT 1.seviye) doğruluk hatası olarak değerlendirildi. Hematokrit testinde 1.seviye kalite kontrol örneği için hesaplanan 0.8-1.2 arasındaki QGI değeri hem kesinlik hem de doğruluk hatası olarak yorumlandı. Sonuç: Çalışmamız, sigma değerlerinin ve QGI oranının, hematoloji laboratuvarının analitik performansını değerlendirmek ve iyileştirmek için kaliteli bir araç olduğunu göstermektedir.
- 3 May 2023
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 21 (1) , 013-022
Tam Kan Sayımında Performans Değerlendirmesi: Sigma Değerleri ve Kalite Hedefi İndeksleri
Amaç: Altı Sigma, klinik laboratuvardaki testlerin performansının izlenmesinde ve iyileştirilmesinde yardımcı olan bir kalite yönetim aracıdır. Kalite hedefi indeksi (quality goal index, QGI) oranı, doğruluk ve kesinlik ile ilgili kalite hedeflerini karşılama durumunu gösterir. Bu çalışmada, Avrupa Dış Kalite Değerlendirme Birliği (European Society for External Quality Assessment, ESFEQA) toplam izin verilen hata (TEa) değerlerini kullanarak tam kan sayımı testleri için sigma değerlerini ve kalite hedefi indeks oranlarını hesaplamayı amaçladık. Gereç ve Yöntem: Çalışmamız Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi Biyokimya Laboratuvarı Hematoloji Ünitesinde retrospektif olarak yapıldı. Testlerin %bias, %CV, TEa değerleri ile Sigma = (TEa - bias)/CV ve QGI= Bias/1.5 CV formülleri kullanılarak hesaplamalar yapıldı. Bulgular: Testlerin sigma düzeyleri ve QGI oranları değerlendirildi. Kullanılan internal kalite kontrol materyallerine göre WBC (tüm seviyeler), RBC (seviye 3), hemoglobin (seviye 2), hematokrit (seviye 2 ve 3), MCV (seviye 2 ve 3) parametrelerinin belirtilen örnekler için performansları >6 sigma ile ideal olarak değerlendirildi. RBC ve hemoglobin parametrelerinin 1.düzey kalite kontrol örneği için performansı ≥3-<4 sigma ile iyi değil olarak kabul edildi. Sigma düzeyi<5 olan parametreler içinde QGI değerleri 1.2 olanlar (PLT 1.seviye) doğruluk hatası olarak değerlendirildi. Hematokrit testinde 1.seviye kalite kontrol örneği için hesaplanan 0.8-1.2 arasındaki QGI değeri hem kesinlik hem de doğruluk hatası olarak yorumlandı. Sonuç: Çalışmamız, sigma değerlerinin ve QGI oranının, hematoloji laboratuvarının analitik performansını değerlendirmek ve iyileştirmek için kaliteli bir araç olduğunu göstermektedir.
- 1 January 2023
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 69 (06/2023) , 1215-1225
Determination of Complete Blood Count Reference Intervals by an Indirect Method for Newborns, Adults, and Geriatric Ages
Background: The availability of a reliable reference interval is crucial for clinical decision-making. Correctly de-fined reference intervals for different age groups are currently unavailable for many parameters. Our study aim-ed to determine the complete blood count reference intervals in our region from newborn to geriatric ages with an indirect method.Methods: The study was carried out at Marmara University Pendik E & R Hospital Biochemistry Laboratory be-tween January 2018 and May 2019 using the laboratory information system data. The complete blood count (CBC) measurements were performed by Unicel DxH 800 Coulter Cellular Analysis System (Beckman Coulter, FL, USA). A total of 14,014,912 test results belonging to infants, children, adolescents, adults, and geriatric ages were collected. We analyzed 22 CBC parameters, and an indirect method was used for reference interval determi-nation. Data were analyzed according to the Clinical and Laboratory Standards Institute (CLSI) C28-A3 guide-line for defining, establishing, and verifying reference intervals in the clinical laboratory.Results: We have established reference intervals from newborn to geriatric ages for 22 hematology parameters [hemoglobin (Hb), hematocrit (Hct), red blood cell (RBC), mean red cell volume (MCV), mean red cell hemoglo-bin (MCH), mean red cell hemoglobin concentration (MCHC), red cell distribution width (RDW), white blood cell (WBC) count, WBC differentials, including percentages and absolute counts, platelet count, platelet distribution width (PDW), mean platelet volume (MPV) and plateletcrit (PCT)].Conclusions: Our study showed that reference intervals established with data obtained from clinical laboratory databases are comparable to those created using direct methods.(Clin. Lab. 2023;69:1215-1225. DOI: 10.7754/Clin.Lab.2022.220919)
- 1 January 2023
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 69 (06/2023) , 1215-1225
Determination of Complete Blood Count Reference Intervals by an Indirect Method for Newborns, Adults, and Geriatric Ages
Background: The availability of a reliable reference interval is crucial for clinical decision-making. Correctly de-fined reference intervals for different age groups are currently unavailable for many parameters. Our study aim-ed to determine the complete blood count reference intervals in our region from newborn to geriatric ages with an indirect method.Methods: The study was carried out at Marmara University Pendik E & R Hospital Biochemistry Laboratory be-tween January 2018 and May 2019 using the laboratory information system data. The complete blood count (CBC) measurements were performed by Unicel DxH 800 Coulter Cellular Analysis System (Beckman Coulter, FL, USA). A total of 14,014,912 test results belonging to infants, children, adolescents, adults, and geriatric ages were collected. We analyzed 22 CBC parameters, and an indirect method was used for reference interval determi-nation. Data were analyzed according to the Clinical and Laboratory Standards Institute (CLSI) C28-A3 guide-line for defining, establishing, and verifying reference intervals in the clinical laboratory.Results: We have established reference intervals from newborn to geriatric ages for 22 hematology parameters [hemoglobin (Hb), hematocrit (Hct), red blood cell (RBC), mean red cell volume (MCV), mean red cell hemoglo-bin (MCH), mean red cell hemoglobin concentration (MCHC), red cell distribution width (RDW), white blood cell (WBC) count, WBC differentials, including percentages and absolute counts, platelet count, platelet distribution width (PDW), mean platelet volume (MPV) and plateletcrit (PCT)].Conclusions: Our study showed that reference intervals established with data obtained from clinical laboratory databases are comparable to those created using direct methods.(Clin. Lab. 2023;69:1215-1225. DOI: 10.7754/Clin.Lab.2022.220919)
- 22 September 2022
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 38 (4) , 382-390
Evaluation of the Diagnostic Value of Cell Population Data in Sepsis in Comparison to Localized Infection, Chronic Inflammation, and Noninfectious Inflammation Cases
Introduction: Sepsis, defined as an increase of 2 points or more in the sequential organ failure assessment score, is a life-threatening organ dysfunction caused by the dysregulated host response to infection. Volume-conductivity-scatter (VCS) parameters of cell counters which are known as cell population data (CPD) have been suggested to be beneficial in diagnosing sepsis. We aimed to evaluate the diagnostic value of CPD parameters in sepsis in comparison to nonsystemic infection cases (NSI) and non-infectious acute and chronic inflammatory conditions. Materials and Methods: We prospectively included four groups of patients” data: sepsis (n = 66), localized infection (pneumonia, n = 59), chronic inflammation (rheumatoid arthritis, n = 92) and noninfectious inflammation (coronary artery bypass graft operation, n = 56) groups, according to their clinical status and laboratory results. Samples for cell counting and serum markers were collected on the same day of culture collection. VCS parameters were measured by Unicel DxH800 Coulter Cellular Analyzer (Beckman Coulter, USA). Results: Mean neutrophil volume (MN-V-NE), was highest in the sepsis group [155(149-168)] compared to the localized infection [148(140-158)], chronic inflammation [144.5(142-149)] and noninfectious inflammation [149(145.2-153.7)] (P = 0.001, P < 0.001, P < 0.001, respectively). Neutrophil volume SD (SD-V-NE) was higher in the sepsis [21(18.8-23.7)], significantly differentiating sepsis from other groups. The area under curves of procalcitonin and hs-C-reactive protein were 0.846 and 0.837, respectively, in the receiver-operating characteristic curves (ROC) . CPD combinations, (SD-V NE + SD-V LY + SD-V MO), (SD-V NE + SD-V MO), and (MN-V NE + SD-V NE + SD-C LY + SD-V MO) had greater AUC values than procalcitonin’s. Conclusion: VCS parameters might be promising for differentiating sepsis and non-sepsis cases. Additionally, obtaining these data routinely makes their prospects promising without any additional cost and time.
- 22 September 2022
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 38 (4) , 382-390
Evaluation of the Diagnostic Value of Cell Population Data in Sepsis in Comparison to Localized Infection, Chronic Inflammation, and Noninfectious Inflammation Cases
Introduction: Sepsis, defined as an increase of 2 points or more in the sequential organ failure assessment score, is a life-threatening organ dysfunction caused by the dysregulated host response to infection. Volume-conductivity-scatter (VCS) parameters of cell counters which are known as cell population data (CPD) have been suggested to be beneficial in diagnosing sepsis. We aimed to evaluate the diagnostic value of CPD parameters in sepsis in comparison to nonsystemic infection cases (NSI) and non-infectious acute and chronic inflammatory conditions. Materials and Methods: We prospectively included four groups of patients” data: sepsis (n = 66), localized infection (pneumonia, n = 59), chronic inflammation (rheumatoid arthritis, n = 92) and noninfectious inflammation (coronary artery bypass graft operation, n = 56) groups, according to their clinical status and laboratory results. Samples for cell counting and serum markers were collected on the same day of culture collection. VCS parameters were measured by Unicel DxH800 Coulter Cellular Analyzer (Beckman Coulter, USA). Results: Mean neutrophil volume (MN-V-NE), was highest in the sepsis group [155(149-168)] compared to the localized infection [148(140-158)], chronic inflammation [144.5(142-149)] and noninfectious inflammation [149(145.2-153.7)] (P = 0.001, P < 0.001, P < 0.001, respectively). Neutrophil volume SD (SD-V-NE) was higher in the sepsis [21(18.8-23.7)], significantly differentiating sepsis from other groups. The area under curves of procalcitonin and hs-C-reactive protein were 0.846 and 0.837, respectively, in the receiver-operating characteristic curves (ROC) . CPD combinations, (SD-V NE + SD-V LY + SD-V MO), (SD-V NE + SD-V MO), and (MN-V NE + SD-V NE + SD-C LY + SD-V MO) had greater AUC values than procalcitonin’s. Conclusion: VCS parameters might be promising for differentiating sepsis and non-sepsis cases. Additionally, obtaining these data routinely makes their prospects promising without any additional cost and time.
- Open Access
- 24 August 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 47 (5) , 686-689
A case of falsely elevated D-dimer result
Objectives: Heterophile antibodies can cause interferences in immunometric assays. While many tests are shown to be affected by interference from heterophilic antibodies, the D-dimer test has rarely been reported to be affected. With this case, we report an elevated D-dimer measurement which was not compatible with the clinical presentation. Case presentation: A 41-year-old patient who was admitted to hospital with heart palpitations had a D-dimer elevation irrelevant to his clinical condition. D-dimer measurements were repeated in new samples directly and after being treated in heterophilic blocking tube with two different reagent lots of a latex-based automated immunoturbidimetric assay and an immunoturbidometric assay. D-dimer values were normalized (0–0.5 mg/L) when we used a new lot of reagent on the same instrument or measured by an immunoturbidometric method on the chemistry analyzer. After treatment with HBT, all samples revealed D-dimer results within the reference ranges. Conclusions: The presence of heterophile antibodies in a sample should be considered when an elevated D-dimer value that is not compatible with the clinical presentation is encountered. Apart from the patient’s HA’s causing false results, sporadic susceptibility of the reagents should also be kept in mind as a possibility.
- 24 August 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 47 (5) , 686-689
Open AccessA case of falsely elevated D-dimer result
Objectives: Heterophile antibodies can cause interferences in immunometric assays. While many tests are shown to be affected by interference from heterophilic antibodies, the D-dimer test has rarely been reported to be affected. With this case, we report an elevated D-dimer measurement which was not compatible with the clinical presentation. Case presentation: A 41-year-old patient who was admitted to hospital with heart palpitations had a D-dimer elevation irrelevant to his clinical condition. D-dimer measurements were repeated in new samples directly and after being treated in heterophilic blocking tube with two different reagent lots of a latex-based automated immunoturbidimetric assay and an immunoturbidometric assay. D-dimer values were normalized (0–0.5 mg/L) when we used a new lot of reagent on the same instrument or measured by an immunoturbidometric method on the chemistry analyzer. After treatment with HBT, all samples revealed D-dimer results within the reference ranges. Conclusions: The presence of heterophile antibodies in a sample should be considered when an elevated D-dimer value that is not compatible with the clinical presentation is encountered. Apart from the patient’s HA’s causing false results, sporadic susceptibility of the reagents should also be kept in mind as a possibility.
- Open Access
- 30 September 2019
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 4 (3) , 325-338
Multipl Skleroz Hastalarında Metilprednizolon ve İnterferon Tedavisinin Kan Vitamin B12, Folik Asid ve Homosistein Düzeyleri Üzerine Etkisi
Changes in blood homocysteine, vitamin B12 and folic acid levels have been reported during multiple sclerosis (MS) and treatment period; however, the exact mechanism has not been enlightened. We investigated the changes of serum B12, folic acid, and plasma homocysteine levels before and after high-dose IV methylprednisolone treatment and after interferon-β treatment in patients admitted with an acute attack of MS.31 patients followed for clinically definite MS (8 male, 23 female) and 10 control individuals were included in the study. 20 patients were admitted with an acute attack and were administered 1000 mg/day methylprednisolone for 7 days. 27 patients started interferon-β treatment. Serum B12, folic acid, and plasma Homocysteine levels measured before and after the 1 month after high dose steroid treatment and after 3-month interferon-β treatment were compared with pre-treatment levels and healthy controls. Baseline B12 levels were lower in patients with MS than in healthy controls, which is consistent with previous findings. Both methylprednisolone and interferon-β treatments increased serum B12 and folic acid levels compared with baseline; however, only the increase following methylprednisolone treatment was statistically significant.In our study, elevated B12 and folic acid levels and decreasing of homocysteine levels without reaching statistical significance following methylprednisolone have caused different debates.
- 30 September 2019
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 4 (3) , 325-338
Open AccessMultipl Skleroz Hastalarında Metilprednizolon ve İnterferon Tedavisinin Kan Vitamin B12, Folik Asid ve Homosistein Düzeyleri Üzerine Etkisi
Changes in blood homocysteine, vitamin B12 and folic acid levels have been reported during multiple sclerosis (MS) and treatment period; however, the exact mechanism has not been enlightened. We investigated the changes of serum B12, folic acid, and plasma homocysteine levels before and after high-dose IV methylprednisolone treatment and after interferon-β treatment in patients admitted with an acute attack of MS.31 patients followed for clinically definite MS (8 male, 23 female) and 10 control individuals were included in the study. 20 patients were admitted with an acute attack and were administered 1000 mg/day methylprednisolone for 7 days. 27 patients started interferon-β treatment. Serum B12, folic acid, and plasma Homocysteine levels measured before and after the 1 month after high dose steroid treatment and after 3-month interferon-β treatment were compared with pre-treatment levels and healthy controls. Baseline B12 levels were lower in patients with MS than in healthy controls, which is consistent with previous findings. Both methylprednisolone and interferon-β treatments increased serum B12 and folic acid levels compared with baseline; however, only the increase following methylprednisolone treatment was statistically significant.In our study, elevated B12 and folic acid levels and decreasing of homocysteine levels without reaching statistical significance following methylprednisolone have caused different debates.